Science News
from research organizations

Scientists discover new drug candidates for cystic fibrosis and other diseases

Date:
December 13, 2011
Source:
Federation of American Societies for Experimental Biology
Summary:
A new discovery may lead to pharmaceutical breakthroughs for illnesses involving the hydration of cells lining the inner surfaces of our body's organs and tissues. Researchers report how high-throughput screening identifies small-molecule drug candidates, helping cells bypass defective channels that move salt and water through cell membranes. By activating an alternative chloride channel "TMEM16A" conditions such as cystic fibrosis and slow-transit constipation can be treated.
Share:
       
FULL STORY

A new discovery by Californian scientists may lead to a pharmaceutical breakthrough for a wide range of illnesses that involve the hydration of cells that line the inner surfaces of our body's organs and tissues. In a new report appearing in the FASEB Journal, the researchers describe how they used high-throughput screening to identify small-molecule drug candidates which help cells bypass defective channels that normally move salt and water through cell membranes. These drug candidates work by activating an alternative chloride channel called "TMEM16A" that might be effective in treating conditions such as cystic fibrosis, dry eye and dry mouth diseases and slow-transit constipation.

"Further pre-clinical development of the chloride channel activators identified in our study may lead to new drug therapies for cystic fibrosis, dry eye and mouth syndromes, and certain types of constipation," said Alan S. Verkman, M.D., Ph.D., study author from the Department of Medicine at the University of California, San Francisco.

Verkman and colleagues discovered these compounds by using high-throughput screening, in which more than 100,000 drug-like compounds were tested for their ability to activate the TMEM16A channel. Active compounds coming from the screen were further improved and tested in cell and mouse models. These compounds were found to help facilitate salt and water movement, making them promising drug candidates.

"Scientists have known for decades that cells have more than one way to move salt and water. Indeed, over the years many useful drugs have been developed that influence these movements in the heart and kidneys," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "This discovery is important not only because it identifies a new channel present all over the body, but finds a promising agent to activate it. As further drug candidates are devised to target TMEM16A, this work may lead to clinical advances of major significance."


Story Source:

The above post is reprinted from materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. W. Namkung, Z. Yao, W. E. Finkbeiner, A. S. Verkman. Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction. The FASEB Journal, 2011; 25 (11): 4048 DOI: 10.1096/fj.11-191627

Cite This Page:

Federation of American Societies for Experimental Biology. "Scientists discover new drug candidates for cystic fibrosis and other diseases." ScienceDaily. ScienceDaily, 13 December 2011. <www.sciencedaily.com/releases/2011/11/111101125822.htm>.
Federation of American Societies for Experimental Biology. (2011, December 13). Scientists discover new drug candidates for cystic fibrosis and other diseases. ScienceDaily. Retrieved July 4, 2015 from www.sciencedaily.com/releases/2011/11/111101125822.htm
Federation of American Societies for Experimental Biology. "Scientists discover new drug candidates for cystic fibrosis and other diseases." ScienceDaily. www.sciencedaily.com/releases/2011/11/111101125822.htm (accessed July 4, 2015).

Share This Page: